NASDAQ · CANC
Tema Oncology ETF
$42.29-$0.06 (-0.15%)
Tema Oncology ETF’s quoted price sits in the upper half of its reported 52-week range, 10.02% below the high.
Loading market information…
AMEX · MGOV · USD
Stock price, dividends
Quote as of Oct 30, 2026, 07:59 PM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
First Trust Intermediate Government Opportunities ETF’s quoted price sits in the lower half of its reported 52-week range, 6.87% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
First Trust Intermediate Government Opportunities ETF’s forward annual dividend is $0.84 per share, paid monthly. The forward yield is 4.31% at the quoted price. Future payments can change.
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
THE COMPANY BEHIND THE TICKER
The First Trust Intermediate Government Opportunities ETF endeavors to achieve the greatest possible total return over the long term. Under typical market conditions, the fund will commit at least 80% of its net assets, including any capital borrowed for investment purposes, to debt instruments issued or backed by the United States government, its agencies, or government-sponsored entities, collectively known as "Government Securities." Its holdings in these Government Securities encompass publicly traded U.S. Treasury products, such as bonds, notes, and bills, alongside mortgage-backed instruments like pass-through securities, collateralized mortgage obligations (CMOs), and commercial mortgage-backed securities (CMBS). The fund also possesses the flexibility to allocate capital to exchange-traded funds that primarily invest in Government Securities, as well as derivative instruments including futures contracts, options, and swap agreements that derive their value from Government Securities. Additionally, the fund may acquire mortgage-related securities via "to-be-announced" transactions, which include mortgage dollar rolls, and can invest in both fixed-rate and floating-rate securities.
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 31, 2026, 05:21 PM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
Completed calendar years and any current-year payments shown separately. Current-year totals are incomplete until all payments are made.
See annual income at the current dividend rate.
Assumes the annual dividend stays unchanged. Payments follow the company’s schedule. Excludes taxes, fees and currency changes.
KEEP COMPARING
$42.29-$0.06 (-0.15%)
Tema Oncology ETF’s quoted price sits in the upper half of its reported 52-week range, 10.02% below the high.
$47.25-$2.90 (-5.77%)
TCW Artificial Intelligence ETF’s quoted price sits in the upper half of its reported 52-week range, 18.25% below the high.
$75.52-$0.89 (-1.16%)
Calvert US Mid-Cap Core Responsible Index ETF’s quoted price sits in the upper half of its reported 52-week range, 4.37% below the high.
$19.11+$0.03 (+0.16%)
Academy Veteran Impact ETF’s quoted price sits in the lower half of its reported 52-week range, 6.73% below the high.
$41.76-$0.54 (-1.29%)
Overlay Shares Hedged Large Cap Equity ETF’s quoted price sits in the upper half of its reported 52-week range, 3.29% below the high.
$20.72+$0.12 (+0.58%)
First Trust Securitized Plus ETF’s quoted price sits in the lower half of its reported 52-week range, 5.95% below the high.
$26.78-$0.91 (-3.28%)
Touchstone Sands Capital US Select Growth ETF’s quoted price sits in the lower half of its reported 52-week range, 12.57% below the high.
$32.24-$0.54 (-1.65%)
Innovator Emerging Markets Power Buffer ETF - April’s quoted price sits in the upper half of its reported 52-week range, 6.46% below the high.
